Pnc Financial Services »

Cartesian Therapeutics shares owned by Pnc Financial Services

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $36 5 7.20

More positions owned by Pnc Financial Services

Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Et (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Rus 1000 Grw E (IWF)
Erie Indty Cl A (ERIE)
V.F. Corporation (VFC)

View all positions for Pnc Financial Services

Top funds holding Cartesian Therapeutics

FMR
BlackRock
Vanguard Group
683 Capital Management
Erste Asset Management GmbH
Geode Capital Management
State Street Corporation
Marshall Wace
Privium Fund Management B.V.
Jacobs Levy Equity Management
Northern Trust
Citadel Advisors
GSA Capital Partners
UBS Group
Susquehanna International

View all funds holding Cartesian Therapeutics